loadpatents
name:-0.030763149261475
name:-0.031405925750732
name:-0.0075979232788086
COHEN; Benjamin M. Patent Filings

COHEN; Benjamin M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for COHEN; Benjamin M..The latest application filed is for "substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation".

Company Profile
7.23.27
  • COHEN; Benjamin M. - Princeton NJ
  • Cohen; Benjamin M. - Cranford NJ
  • Cohen; Benjamin M. - Cranfor NJ
  • Cohen; Benjamin M - Gilon IL
  • Cohen; Benjamin M. - Gilon IL
  • Cohen; Benjamin M. - DN Misgav IL
  • Cohen; Benjamin M. - Misgav IL
  • Cohen; Benjamin M. - Skokie IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted Quinolinylcyclohexylpropanamide Compounds And Improved Methods For Their Preparation
App 20220267273 - DELMONTE; Albert J. ;   et al.
2022-08-25
Substituted Quinolinylcyclohexylpropanamide Compounds And Improved Methods For Their Preparation
App 20220127233 - DELMONTE; Albert J. ;   et al.
2022-04-28
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20220125797 - Cohen; Benjamin M. ;   et al.
2022-04-28
Process For The Preparation Of A Cyclic Dinucleotide
App 20220064205 - Schmidt; Michael Anthony ;   et al.
2022-03-03
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- e-2,6-dione and compositions comprising and methods of using the same
Grant 11,241,439 - Cohen , et al. February 8, 2
2022-02-08
Substituted quinolinylcyclohexylpropanamide compounds and improved methods for their preparation
Grant 11,236,048 - Delmonte , et al. February 1, 2
2022-02-01
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20200360395 - Cohen; Benjamin M. ;   et al.
2020-11-19
Substituted Quinolinylcyclohexylpropanamide Compounds And Improved Methods For Their Preparation
App 20200123109 - DELMONTE; Albert J. ;   et al.
2020-04-23
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl) oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
Grant 10,596,180 - Cohen , et al.
2020-03-24
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions
App 20190365772 - Cohen; Benjamin M. ;   et al.
2019-12-05
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- e-2,6-dione and compositions comprising and methods of using the same
Grant 10,463,672 - Cohen , et al. No
2019-11-05
Object instance identification using three-dimensional spatial configuration
Grant 10,311,593 - Cohen , et al.
2019-06-04
Solid Forms Of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, And Their Pharmaceutical Compositions And Uses
App 20180305333 - Muller; George W. ;   et al.
2018-10-25
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20180200255 - Cohen; Benjamin M. ;   et al.
2018-07-19
Processes for the preparation of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- e-2,6-dione and pharmaceutically acceptable forms thereof
Grant 9,975,872 - Traverse , et al. May 22, 2
2018-05-22
Object Instance Identification Using Three-dimensional Spatial Configuration
App 20180137386 - COHEN; BENJAMIN M ;   et al.
2018-05-17
Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
Grant 9,969,713 - Muller , et al. May 15, 2
2018-05-15
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- e-2,6-dione and compositions comprising and methods of using the same
Grant 9,884,062 - Cohen , et al. February 6, 2
2018-02-06
Solid Forms Of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, And Their Pharmaceutical Compositions And Uses
App 20170342050 - Muller; George W. ;   et al.
2017-11-30
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20170258803 - Cohen; Benjamin M. ;   et al.
2017-09-14
Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
Grant 9,751,853 - Muller , et al. September 5, 2
2017-09-05
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- e-2,6-dione and compositions comprising and methods of using the same
Grant 9,629,849 - Cohen , et al. April 25, 2
2017-04-25
Processes For The Preparation Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Pharmaceutically Acceptable Forms Thereof
App 20160251333 - TRAVERSE; John F. ;   et al.
2016-09-01
Solid Forms Of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, And Their Pharmaceutical Compositions And Uses
App 20160214957 - MULLER; George W. ;   et al.
2016-07-28
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20160136174 - COHEN; Benjamin M. ;   et al.
2016-05-19
Processes for the preparation of (S)-3-(4- (4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dion- e and pharmaceutically acceptable forms thereof
Grant 9,309,220 - Traverse , et al. April 12, 2
2016-04-12
Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione
Grant 9,303,014 - Ruchelman , et al. April 5, 2
2016-04-05
Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione
Grant 9,266,858 - Ruchelman , et al. February 23, 2
2016-02-23
Real-time advisor system with projected augmentable annotations
Grant 9,258,521 - Cohen , et al. February 9, 2
2016-02-09
Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
Grant 9,249,121 - Muller , et al. February 2, 2
2016-02-02
Synthesis Of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione
App 20160009685 - RUCHELMAN; Alexander L. ;   et al.
2016-01-14
Salts and solid forms of (S)-3-(4- (4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dion- e and compositions comprising and methods of using the same
Grant 9,221,788 - Cohen , et al. December 29, 2
2015-12-29
Synthesis Of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione
App 20150274694 - RUCHELMAN; Alexander L. ;   et al.
2015-10-01
Synthesis of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,8-dione
Grant 9,067,912 - Ruchelman , et al. June 30, 2
2015-06-30
Solid Forms Of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, And Their Pharmaceutical Compositions And Uses
App 20140378484 - MULLER; George W. ;   et al.
2014-12-25
Synthesis Of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione
App 20140330016 - RUCHELMAN; Alexander L. ;   et al.
2014-11-06
Real-time Advisor System with Projected Augmentable Annotations
App 20140327725 - Cohen; Benjamin M. ;   et al.
2014-11-06
Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
Grant 8,802,685 - Muller , et al. August 12, 2
2014-08-12
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20140046057 - Cohen; Benjamin M. ;   et al.
2014-02-13
Processes For The Preparation Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Pharmaceutically Acceptable Forms Thereof
App 20140046058 - Traverse; John F. ;   et al.
2014-02-13
Solid Forms Of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, And Their Pharmaceutical Compositions And Uses
App 20120232100 - Muller; George ;   et al.
2012-09-13
Process for the production of a crystalline glucagon receptor antagonist compound
Grant 8,232,413 - Cohen , et al. July 31, 2
2012-07-31
Robust encoding of metadata in lossy encoded images
Grant 8,155,457 - Cohen April 10, 2
2012-04-10
Process For The Production Of A Crystalline Glucagon Receptor Antagonist Compound
App 20100184995 - Cohen; Benjamin M. ;   et al.
2010-07-22
Robust Encoding of Metadata in Lossy Encoded Images
App 20100124353 - Cohen; Benjamin M.
2010-05-20
Power optimized request response communication protocol with timer mechanism to enforce client to generate request
Grant 7,016,710 - Carmeli , et al. March 21, 2
2006-03-21
Method and apparatus for diagnosing hemostasis
Grant 6,797,519 - Cohen , et al. September 28, 2
2004-09-28
Method and apparatus for diagnosing hemostasis
App 20030073244 - Cohen, Eli ;   et al.
2003-04-17
Power optimized request response communication protocol with timer mechanism to enforce client to generate request
App 20030027608 - Carmeli, Boaz ;   et al.
2003-02-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed